Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Allergy
Published in: Clinical and Translational Allergy 1/2016

Open Access 01-12-2016 | Review

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

Authors: J. Bousquet, J. Farrell, G. Crooks, P. Hellings, E. H. Bel, M. Bewick, N. H. Chavannes, J. Correia de Sousa, A. A. Cruz, T. Haahtela, G. Joos, N. Khaltaev, J. Malva, A. Muraro, M. Nogues, S. Palkonen, S. Pedersen, C. Robalo-Cordeiro, B. Samolinski, T. Strandberg, A. Valiulis, A. Yorgancioglu, T. Zuberbier, A. Bedbrook, W. Aberer, M. Adachi, A. Agusti, C. A. Akdis, M. Akdis, J. Ankri, A. Alonso, I. Annesi-Maesano, I. J. Ansotegui, J. M. Anto, S. Arnavielhe, H. Arshad, C. Bai, I. Baiardini, C. Bachert, A. K. Baigenzhin, C. Barbara, E. D. Bateman, B. Beghé, A. Ben Kheder, K. S. Bennoor, M. Benson, K. C. Bergmann, T. Bieber, C. Bindslev-Jensen, L. Bjermer, H. Blain, F. Blasi, A. L. Boner, M. Bonini, S. Bonini, S. Bosnic-Anticevitch, L. P. Boulet, R. Bourret, P. J. Bousquet, F. Braido, A. H. Briggs, C. E. Brightling, J. Brozek, R. Buhl, P. G. Burney, A. Bush, F. Caballero-Fonseca, D. Caimmi, M. A. Calderon, P. M. Calverley, P. A. M. Camargos, G. W. Canonica, T. Camuzat, K. H. Carlsen, W. Carr, A. Carriazo, T. Casale, A. M. Cepeda Sarabia, L. Chatzi, Y. Z. Chen, R. Chiron, E. Chkhartishvili, A. G. Chuchalin, K. F. Chung, G. Ciprandi, I. Cirule, L. Cox, D. J. Costa, A. Custovic, R. Dahl, S. E. Dahlen, U. Darsow, G. De Carlo, F. De Blay, T. Dedeu, D. Deleanu, E. De Manuel Keenoy, P. Demoly, J. A. Denburg, P. Devillier, A. Didier, A. T. Dinh-Xuan, R. Djukanovic, D. Dokic, H. Douagui, G. Dray, R. Dubakiene, S. R. Durham, M. S. Dykewicz, Y. El-Gamal, R. Emuzyte, L. M. Fabbri, M. Fletcher, A. Fiocchi, A. Fink Wagner, J. Fonseca, W. J. Fokkens, F. Forastiere, P. Frith, M. Gaga, A. Gamkrelidze, J. Garces, J. Garcia-Aymerich, B. Gemicioğlu, J. E. Gereda, S. González Diaz, M. Gotua, I. Grisle, L. Grouse, Z. Gutter, M. A. Guzmán, L. G. Heaney, B. Hellquist-Dahl, D. Henderson, A. Hendry, J. Heinrich, D. Heve, F. Horak, J. O’. B. Hourihane, P. Howarth, M. Humbert, M. E. Hyland, M. Illario, J. C. Ivancevich, J. R. Jardim, E. J. Jares, C. Jeandel, C. Jenkins, S. L. Johnston, O. Jonquet, K. Julge, K. S. Jung, J. Just, I. Kaidashev, M. R. Kaitov, O. Kalayci, A. F. Kalyoncu, T. Keil, P. K. Keith, L. Klimek, B. Koffi N’Goran, V. Kolek, G. H. Koppelman, M. L. Kowalski, I. Kull, P. Kuna, V. Kvedariene, B. Lambrecht, S. Lau, D. Larenas-Linnemann, D. Laune, L. T. T. Le, P. Lieberman, B. Lipworth, J. Li, K. Lodrup Carlsen, R. Louis, W. MacNee, Y. Magard, A. Magnan, B. Mahboub, A. Mair, I. Majer, M. J. Makela, P. Manning, S. Mara, G. D. Marshall, M. R. Masjedi, P. Matignon, M. Maurer, S. Mavale-Manuel, E. Melén, E. Melo-Gomes, E. O. Meltzer, A. Menzies-Gow, H. Merk, J. P. Michel, N. Miculinic, F. Mihaltan, B. Milenkovic, G. M. Y. Mohammad, M. Molimard, I. Momas, A. Montilla-Santana, M. Morais-Almeida, M. Morgan, R. Mösges, J. Mullol, S. Nafti, L. Namazova-Baranova, R. Naclerio, A. Neou, H. Neffen, K. Nekam, B. Niggemann, G. Ninot, T. D. Nyembue, R. E. O’Hehir, K. Ohta, Y. Okamoto, K. Okubo, S. Ouedraogo, P. Paggiaro, I. Pali-Schöll, P. Panzner, N. Papadopoulos, A. Papi, H. S. Park, G. Passalacqua, I. Pavord, R. Pawankar, R. Pengelly, O. Pfaar, R. Picard, B. Pigearias, I. Pin, D. Plavec, D. Poethig, W. Pohl, T. A. Popov, F. Portejoie, P. Potter, D. Postma, D. Price, K. F. Rabe, F. Raciborski, F. Radier Pontal, S. Repka-Ramirez, S. Reitamo, S. Rennard, F. Rodenas, J. Roberts, J. Roca, L. Rodriguez Mañas, C. Rolland, M. Roman Rodriguez, A. Romano, J. Rosado-Pinto, N. Rosario, L. Rosenwasser, M. Rottem, D. Ryan, M. Sanchez-Borges, G. K. Scadding, H. J. Schunemann, E. Serrano, P. Schmid-Grendelmeier, H. Schulz, A. Sheikh, M. Shields, N. Siafakas, Y. Sibille, T. Similowski, F. E. R. Simons, J. C. Sisul, I. Skrindo, H. A. Smit, D. Solé, T. Sooronbaev, O. Spranger, R. Stelmach, P. J. Sterk, J. Sunyer, C. Thijs, T. To, A. Todo-Bom, M. Triggiani, R. Valenta, A. L. Valero, E. Valia, E. Valovirta, E. Van Ganse, M. van Hage, O. Vandenplas, T. Vasankari, B. Vellas, J. Vestbo, G. Vezzani, P. Vichyanond, G. Viegi, C. Vogelmeier, T. Vontetsianos, M. Wagenmann, B. Wallaert, S. Walker, D. Y. Wang, U. Wahn, M. Wickman, D. M. Williams, S. Williams, J. Wright, B. P. Yawn, P. K. Yiallouros, O. M. Yusuf, A. Zaidi, H. J. Zar, M. E. Zernotti, L. Zhang, N. Zhong, M. Zidarn, J. Mercier

Published in: Clinical and Translational Allergy | Issue 1/2016

Login to get access

Abstract

Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.
Appendix
Available only for authorised users
Literature
1.
Uvin P. Fighting hunger at the grassroots: paths to scaling up. World Dev. 1995;23(6):937–9.CrossRef
2.
Bousquet J, Michel J, Standberg T, Crooks G, Iakovidis I, Gomez M. The European Innovation Partnership on Active and Healthy Ageing: the European Geriatric Medicine introduces the EIP on AHA column. Eur Geriatr Med. 2014;5(6):361–2.CrossRef
3.
Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J. 2014;44(2):304–23.CrossRefPubMed
4.
5.
Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007;62(3):216–23.CrossRefPubMed
6.
Bousquet J, Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. Global alliance against chronic respiratory diseases. World Health Organization. ISBN 978 92 4 156346 8. 2007; 148 pp.
7.
Samolinski B, Fronczak A, Wlodarczyk A, Bousquet J. Council of the European Union conclusions on chronic respiratory diseases in children. Lancet. 2012;379(9822):e45–6.CrossRefPubMed
8.
Samolinski B, Fronczak A, Kuna P, Akdis CA, Anto JM, Bialoszewski AZ, et al. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy. 2012;67(6):726–31.CrossRefPubMedPubMedCentral
9.
Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, et al. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011;378(9789):449–55.CrossRefPubMed
10.
Bousquet J, Tanasescu CC, Camuzat T, Anto JM, Blasi F, Neou A, et al. Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliament. Allergy. 2013;68(5):555–61.CrossRefPubMed
11.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.CrossRefPubMed
12.
Wilson N, Bewick M, Dziworski W. Maintaining health despite chronic illness in the elderly: a multi-disciplinary study visit to the north of England region. Eur Geriatr Med. 2015;6(4):396–400.CrossRef
13.
Yorgancioglu A, Cruz AA, Bousquet J, Khaltaev N, Mendis S, Chuchalin A, et al. The Global Alliance against Respiratory Diseases (GARD) Country report. Prim Care Respir J. 2014;23(1):98–101.CrossRefPubMed
14.
Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings. Cancer, diabetes, heart disease and stroke, chronic respiratory disease. WHO, editor, 2010.
15.
Fairall L, Bateman E, Cornick R, Faris G, Timmerman W, Folb N, et al. Innovating to improve primary care in less developed countries: towards a global model. BMC Innov. 2015;1(4):196–203.CrossRef
16.
Bousquet J, Dahl R, Khaltaev N. GARD (Global Alliance against chronic Respiratory Diseases). Rev Mal Respir. 2006;23(4 Pt 2):10S73–5.PubMed
17.
Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010;126(5):926–38.CrossRefPubMed
18.
Bousquet J, Jorgensen C, Dauzat M, Cesario A, Camuzat T, Bourret R, et al. Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. Curr Pharm Des. 2014;20(38):5928–44.CrossRefPubMed
19.
Bousquet J, Anto JM, Demoly P, Schunemann HJ, Togias A, Akdis M, et al. Severe chronic allergic (and related) diseases: a uniform approach—a MeDALL–GA2LEN–ARIA position paper. Int Arch Allergy Immunol. 2012;158(3):216–31.CrossRefPubMed
20.
Bousquet J, Schunemann HJ, Bousquet PJ, Bachert C, Canonica GW, Casale TB, et al. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA–GA2LEN statement. Allergy. 2011;66(6):765–74.CrossRefPubMed
21.
Bousquet J, Schunemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, et al. Allergic rhinitis and its impact on asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012;130(5):1049–62.CrossRefPubMed
22.
Bousquet J, Schunemann HJ, Zuberbier T, Bachert C, Baena-Cagnani CE, Bousquet PJ, et al. Development and implementation of guidelines in allergic rhinitis—an ARIA–GA2LEN paper. Allergy. 2010;65(10):1212–21.CrossRefPubMed
23.
Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, Rasi G, van Wijk RG, et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy. 2008;63(1):38–46.CrossRefPubMed
24.
Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466–76.CrossRefPubMed
25.
26.
Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, et al. MACVIA–ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015;70(11):1372–92.CrossRefPubMed
27.
Bousquet J, Anto JM, Berkouk K, Gergen P, Antunes JP, Auge P, et al. Developmental determinants in non-communicable chronic diseases and ageing. Thorax. 2015;70(6):595–7.CrossRefPubMedPubMedCentral
28.
Bousquet J, Kuh D, Bewick M, Strandberg T, Farrell J, Pengelly R, et al. Operational definition of active and healthy ageing (AHA): framework concensus. J Nutr Health Aging. 2015;19(9):955–60.CrossRefPubMed
29.
Bousquet J, Kuh D, Bewick M, Strandberg T, Farrell J, Pengelly R, et al. Operational definition of active and healthy ageing (AHA): report of the meeting held in Montpellier October 21,22-2012. Eur Geriatr Med. 2015;6(2):196–200.CrossRef
30.
Bousquet J, Malva J, Nogues M, Rodriguez-Mañas L, Vellas B, Farrell J, et al. Operational definition of active and healthy ageing (AHA): the European Innovation Partnership (EIP) on AHA Reference Site questionnaire. J Am Med Dir Assoc. 2015;16(12):1020–6.CrossRefPubMed
31.
Malva JO, Bousquet J. Operational definition of active and healthy ageing: roadmap from concept to change of management. Maturitas. 2016;84:3–4.CrossRefPubMed
32.
Nogues M, Jeandel C, Touchon J, Pinto N, Blain H, Leglise M, et al. Living Lab Fragilité MACVIA-LR. Presse Med. 2015;44(Suppl 1):S6–S22.
33.
Samolinski B, Raciborski F, Bousquet J, Kosiniak-Kamysz W, Radziewicz-Winnicki I, Kłak A, et al. Development of Senioral Policy in Poland. Eur Geriatr Med. 2015;6:389–95.CrossRef
34.
Bourret R, Bousquet J, Mercier J, Camuzat T, Bedbrook A, Demoly P, et al. MASK rhinitis, a single tool for integrated care pathways in allergic rhinitis. World Hosp Health Serv. 2015;51(3):36–9.PubMed
35.
Kupczyk M, Haahtela T, Cruz AA, Kuna P. Reduction of asthma burden is possible through National Asthma Plans. Allergy. 2010;65(4):415–9.CrossRefPubMed
36.
Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T, et al. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy. 2011;66(5):596–604.CrossRefPubMed
37.
Bousquet J, Anto JM, Wickman M, Keil T, Valenta R, Haahtela T, et al. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis. Allergy. 2015;70(9):1062–78.CrossRefPubMed
38.
Hartmann A, Linn J. Scaling up: a framework and lessons for development effectiveness from literature and practice. Brookings: Wolfensohn Center for Development; 2008.
39.
Kinnula VL, Vasankari T, Kontula E, Sovijarvi A, Saynajakangas O, Pietinalho A. The 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality. Prim Care Respir J. 2011;20(2):178–83.CrossRefPubMed
40.
Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A 10 year asthma programme in Finland: major change for the better. Thorax. 2006;61(8):663–70.CrossRefPubMedPubMedCentral
41.
Haahtela T, von Hertzen L, Makela M, Hannuksela M. Finnish Allergy Programme 2008–2018—time to act and change the course. Allergy. 2008;63(6):634–45.CrossRefPubMed
42.
Selroos O, Kupczyk M, Kuna P, Lacwik P, Bousquet J, Brennan D, et al. National and regional asthma programmes in Europe. Eur Respir Rev. 2015;24(137):474–83.CrossRefPubMed
43.
Lodrup Carlsen KC, Haahtela T, Carlsen KH, Smith A, Bjerke M, Wickman M, et al. Integrated allergy and asthma prevention and care: report of the MeDALL/AIRWAYS ICPs meeting at the ministry of health and care services, Oslo, Norway. Int Arch Allergy Immunol. 2015;167(1):57–64.CrossRefPubMed
44.
Bousquet J, Kowalski M, Michel J. The senioral policy in Poland uses the expertise of the European Innovation Partnership on Active and Healthy Ageing. Eur Geriatr Med. 2015;6:293–94.CrossRef
45.
Portuguese National Programme for Respiratory Diseases 2012–2016. Portugese Directorate General of Heatlh. 2012.
46.
Yorgancioglu A, Turktas H, Kalayci O, Yardim N, Buzgan T, Kocabas A, et al. The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey). Tuberk Toraks. 2009;57(4):439–52.PubMed
47.
Yorgancioglu A, Yardim N, Ergun P, Karlikaya C, Kocabas A, Mungan D, et al. Integration of GARD Turkey national program with other non-communicable diseases plans in Turkey. Tuberk Toraks. 2010;58(2):213–28.PubMed
48.
Laurendi G, Mele S, Centanni S, Donner CF, Falcone F, Frateiacci S, et al. Global alliance against chronic respiratory diseases in Italy (GARD-Italy): strategy and activities. Respir Med. 2012;106(1):1–8.CrossRefPubMed
49.
Boulet LP, FitzGerald JM, Levy ML, Cruz AA, Pedersen S, Haahtela T, et al. A guide to the translation of the global initiative for asthma (GINA) strategy into improved care. Eur Respir J. 2012;39(5):1220–9.CrossRefPubMed
50.
Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz AA, Drazen JM, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 2015;46(3):622–39.CrossRefPubMedPubMedCentral
51.
Reddel HK, Levy ML. Global Initiative for Asthma Scientific C, Dissemination, Implementation C. The GINA asthma strategy report: what’s new for primary care? NPJ Prim Care. Respir Med. 2015;25:15050.
52.
Bousquet J, Humbert M. GINA 2015: the latest iteration of a magnificent journey. Eur Respir J. 2015;46(3):579–82.CrossRefPubMed
53.
Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.CrossRefPubMed
54.
Fokkens W, Lund V, Mullol J. EP3OS. European position paper on rhinosinusitis and nasal polyps. 2007. Rhinology. 2007;45(Suppl 20):1–139.
55.
Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–73.CrossRefPubMed
56.
Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007;120(2):381–7.CrossRefPubMed
57.
Morais-Almeida M, Pite H, Pereira AM, Todo-Bom A, Nunes C, Bousquet J, et al. Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal. Allergy. 2013;68(9):1150–7.PubMed
58.
Morais-Almeida M, Santos N, Pereira AM, Branco-Ferreira M, Nunes C, Bousquet J, et al. Prevalence and classification of rhinitis in preschool children in Portugal: a nationwide study. Allergy. 2013;68(10):1278–88.CrossRefPubMed
59.
Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147–334.CrossRefPubMed
60.
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl 86):8–160.CrossRefPubMed
61.
Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64(5):669–77.CrossRefPubMed
62.
Padjas A, Kehar R, Aleem S, Mejza F, Bousquet J, Schunemann HJ, et al. Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study. J Allergy Clin Immunol. 2014;133(3):777.e4–783.e4.CrossRef
63.
Glacy J, Putnam K, Godfrey S, Falzon L, Mauger B, Samson D, et al. Treatments for seasonal allergic rhinitis. AHRQ comparative effectiveness reviews. Rockville, 2013.
64.
Grimaldo F, Orduna J, Rodenas F, Garces J, Lozano M. Towards a simulator of integrated long-term care systems for elderly people. Int J Artif Intell Tools. 2014;23:1–24.CrossRef
65.
Rose L, Fraser IM. Patient characteristics and outcomes of a provincial prolonged-ventilation weaning centre: a retrospective cohort study. Can Respir J. 2012;19(3):216–20.CrossRefPubMedPubMedCentral
66.
Glaser E, Abelson H, Garrison K. Putting knowledge to use: facilitating the diffusion of knowledge and the implementation of planned change. San Francisco: Jossey-Bass; 1983.
67.
68.
Bousquet J, Rosado Pinto J, Barbara C, Correira da Sousa J, Fonseca J, Pereira Miguel J, et al. Portugal at the cross road of international chronic respiratory programmes. Rev Port Pneumol. 2015;21(5):230–2.PubMed
69.
Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA. Asthma programme in Finland: a community problem needs community solutions. Thorax. 2001;56(10):806–14.CrossRefPubMedPubMedCentral
70.
Souza-Machado C, Souza-Machado A, Franco R, Ponte EV, Barreto ML, Rodrigues LC, et al. Rapid reduction in hospitalisations after an intervention to manage severe asthma. Eur Respir J. 2010;35(3):515–21.CrossRefPubMed
71.
Cruz AA, Bousquet PJ. The unbearable cost of severe asthma in underprivileged populations. Allergy. 2009;64(3):319–21.CrossRefPubMed
72.
Bousquet J, Bieber T, Fokkens W, Kowalski M, Humbert M, Niggemann B, et al. In Allergy, ‘A new day has begun’. Allergy. 2008;63(6):631–3.CrossRefPubMed
73.
Cruz AA, Souza-Machado A, Franco R, Souza-Machado C, Ponte EV, Moura Santos P, et al. The impact of a program for control of asthma in a low-income setting. World Allergy Organ J. 2010;3(4):167–74.CrossRefPubMedPubMedCentral
74.
Franco R, Santos AC, do Nascimento HF, Souza-Machado C, Ponte E, Souza-Machado A, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health. 2007;7:82.CrossRefPubMedPubMedCentral
75.
Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–78.CrossRefPubMed
76.
Fischer GB, Camargos PA, Mocelin HT. The burden of asthma in children: a Latin American perspective. Paediatr Respir Rev. 2005;6(1):8–13.CrossRefPubMed
77.
Muraro A, Fokkens WJ, Pietikainen S, Borrelli D, Agache I, Bousquet J, et al. European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015). Rhinology. 2015.
78.
Muraro A, Fokkens WJ, Pietikainen S, Borrelli D, Agache I, Bousquet J, et al. European Symposium on Precision Medicine in Allergy and Airways Diseases: report of the European Union Parliament Symposium (October 14, 2015). Allergy. 2015.
79.
Eurobarometer qualitative study. Patient involvement. http://​eceuropaeu/​public_​opinion/​archives/​quali/​ql_​5937_​patient_​enpdf.​ 2012.
80.
Sanna L. Assessing the involvement of the patient community in European commission co-funded health projects: the experience of the value + project. J Ambul Care Manage. 2010;33(3):265–71.CrossRefPubMed
81.
de-Manuel-Keenoy E, David M, Mora J, Prieto L, Domingo C, Orueta J, et al. Activation of stratification strategies and results of the interventions on frail patients of healthcare services (ASSEHS) DG Sanco Project No. 2013 12 04. Eur Geriatr Med. 2014;5(5):342–6.
82.
Bousquet J, Bourquin C, Augé P, Domy P, Bringer J, Camuzat T, et al. MACVIA-LR Reference Site of the European Innovation Partnership on Active and Healthy Ageing. Eur Geriatr Med. 2014;5(6):406–15.CrossRef
83.
Blain H, Abecassis F, Adnet P, Alomène B, Amouyal M, Bardy B, et al. Living Lab Falls-MACVIA-LR: the falls prevention initiative of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) in Languedoc Roussillon. Eur Geriatr Med. 2014;5(6):416–25.CrossRef
84.
O’Caoimh R, Sweeney C, Hynes H, McGladea C, Cornally N, Daly E, et al. COLLaboration on AGEing-COLLAGE: Ireland’s three star reference site for the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). Eur Geriatr Med. 2015;6(6):505–11.CrossRef
85.
Briggs R, Holmerová I, Martin FC, O’Neill D. Towards standards of medical care for physicians in nursing homes. Eur Geriatr Med. 2015;6(4):401–3.CrossRef
86.
Global Alliance against Chronic Respiratory Diseases (GARD). In: 9th general meeting, 14–16 August 2014, Salvador, Brazil. WHO/NMH/MND/CPM/14.1. wwwwhoint. 2014.
87.
Global Alliance against Chronic Respiratory Diseases (GARD). In: 10th general meeting, 1–2 July 2015, Lisbon, Portugal. WHO/NMH/MND/CPM/15.1. wwwwhoint. 2015.
88.
Bousquet J, Grouse L, Zhong N. The fight against chronic respiratory diseases in the elderly: the European Innovation Partnership on Active and Healthy Aging and beyond. J Thorac Dis. 2015;7(1):108–10.PubMedPubMedCentral
89.
Bousquet J, Burney PG, Zuberbier T, Cauwenberge PV, Akdis CA, Bindslev-Jensen C, et al. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’. Allergy. 2009;64(7):969–77.CrossRefPubMed
90.
Bousquet J, Kiley J, Bateman ED, Viegi G, Cruz AA, Khaltaev N, et al. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J. 2010;36(5):995–1001.CrossRefPubMed
91.
Yorgancioglu A, Ozdemir C, Kalayci O, Kalyocu AF, Bachert C, Baena-Cagnani CE, et al. ARIA (Allergic rhinitis and its impact on asthma) Achievements in 10 years and future needs. Tuberk Toraks. 2012;60(1):92–7.CrossRefPubMed
92.
Agache I, Deleanu D, Khaltaev N, Bousquet J. Allergic rhinitis and its impact upon asthma–update (ARIA 2008). Romanian perspective. Pneumologia. 2009;58(4):255–8.PubMed
93.
Bachert C, Jorissen M, Bertrand B, Khaltaev N, Bousquet J. Allergic Rhinitis and its impact on asthma update (ARIA 2008). The Belgian perspective. B-ENT. 2008;4(4):253–7.PubMed
94.
Cagnani CE, Sole D, Diaz SN, Zernotti ME, Sisul JC, Borges MS, et al. Allergic rhinitis update and its impact on asthma (ARIA 2008). Latin American perspective. Rev Alerg Mex. 2009;56(2):56–63.PubMed
95.
Kalayci O, Yorgancioglu A, Kalyoncu F, Khaltaev AN, Bousquet J. Allergic rhinitis and its impact on asthma update (ARIA 2008): the Turkish perspective. Turk J Pediatr. 2008;50(4):307–12.PubMed
96.
Mullol J, Valero A, Alobid I, Bartra J, Navarro AM, Chivato T, et al. Allergic rhinitis and its impact on asthma update (ARIA 2008). The perspective from Spain. J Investig Allergol Clin Immunol. 2008;18(5):327–34.PubMed
97.
Pali-Scholl I, Pohl W, Aberer W, Wantke F, Horak F, Jensen-Jarolim E, et al. Allergic rhinitis and its impact on asthma (ARIA update 2008) The Austrian perspective. Wien Med Wochenschr. 2009;159(3–4):87–92.CrossRefPubMed
98.
Pawankar R, Bunnag C, Chen Y, Fukuda T, Kim YY, Le LT, et al. Allergic rhinitis and its impact on asthma update (ARIA 2008)—western and Asian-Pacific perspective. Asian Pac J Allergy Immunol. 2009;27(4):237–43.PubMed
99.
Canonica G, Bachert C, Hellings P, Ryan D, Valovirta E, Wickman M, et al. Allergen immunotherapy (AIT): a prototype of precision medicine. World Allergy Organ J. 2015;8(1):31.CrossRefPubMedPubMedCentral
100.
Zhang H, Gustafsson M, Nestor C, Chung KF, Benson M. Targeted omics and systems medicine: personalising care. Lancet Respir Med. 2014;2(10):785–7.CrossRefPubMed
Metadata
Title
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
Authors
J. Bousquet
J. Farrell
G. Crooks
P. Hellings
E. H. Bel
M. Bewick
N. H. Chavannes
J. Correia de Sousa
A. A. Cruz
T. Haahtela
G. Joos
N. Khaltaev
J. Malva
A. Muraro
M. Nogues
S. Palkonen
S. Pedersen
C. Robalo-Cordeiro
B. Samolinski
T. Strandberg
A. Valiulis
A. Yorgancioglu
T. Zuberbier
A. Bedbrook
W. Aberer
M. Adachi
A. Agusti
C. A. Akdis
M. Akdis
J. Ankri
A. Alonso
I. Annesi-Maesano
I. J. Ansotegui
J. M. Anto
S. Arnavielhe
H. Arshad
C. Bai
I. Baiardini
C. Bachert
A. K. Baigenzhin
C. Barbara
E. D. Bateman
B. Beghé
A. Ben Kheder
K. S. Bennoor
M. Benson
K. C. Bergmann
T. Bieber
C. Bindslev-Jensen
L. Bjermer
H. Blain
F. Blasi
A. L. Boner
M. Bonini
S. Bonini
S. Bosnic-Anticevitch
L. P. Boulet
R. Bourret
P. J. Bousquet
F. Braido
A. H. Briggs
C. E. Brightling
J. Brozek
R. Buhl
P. G. Burney
A. Bush
F. Caballero-Fonseca
D. Caimmi
M. A. Calderon
P. M. Calverley
P. A. M. Camargos
G. W. Canonica
T. Camuzat
K. H. Carlsen
W. Carr
A. Carriazo
T. Casale
A. M. Cepeda Sarabia
L. Chatzi
Y. Z. Chen
R. Chiron
E. Chkhartishvili
A. G. Chuchalin
K. F. Chung
G. Ciprandi
I. Cirule
L. Cox
D. J. Costa
A. Custovic
R. Dahl
S. E. Dahlen
U. Darsow
G. De Carlo
F. De Blay
T. Dedeu
D. Deleanu
E. De Manuel Keenoy
P. Demoly
J. A. Denburg
P. Devillier
A. Didier
A. T. Dinh-Xuan
R. Djukanovic
D. Dokic
H. Douagui
G. Dray
R. Dubakiene
S. R. Durham
M. S. Dykewicz
Y. El-Gamal
R. Emuzyte
L. M. Fabbri
M. Fletcher
A. Fiocchi
A. Fink Wagner
J. Fonseca
W. J. Fokkens
F. Forastiere
P. Frith
M. Gaga
A. Gamkrelidze
J. Garces
J. Garcia-Aymerich
B. Gemicioğlu
J. E. Gereda
S. González Diaz
M. Gotua
I. Grisle
L. Grouse
Z. Gutter
M. A. Guzmán
L. G. Heaney
B. Hellquist-Dahl
D. Henderson
A. Hendry
J. Heinrich
D. Heve
F. Horak
J. O’. B. Hourihane
P. Howarth
M. Humbert
M. E. Hyland
M. Illario
J. C. Ivancevich
J. R. Jardim
E. J. Jares
C. Jeandel
C. Jenkins
S. L. Johnston
O. Jonquet
K. Julge
K. S. Jung
J. Just
I. Kaidashev
M. R. Kaitov
O. Kalayci
A. F. Kalyoncu
T. Keil
P. K. Keith
L. Klimek
B. Koffi N’Goran
V. Kolek
G. H. Koppelman
M. L. Kowalski
I. Kull
P. Kuna
V. Kvedariene
B. Lambrecht
S. Lau
D. Larenas-Linnemann
D. Laune
L. T. T. Le
P. Lieberman
B. Lipworth
J. Li
K. Lodrup Carlsen
R. Louis
W. MacNee
Y. Magard
A. Magnan
B. Mahboub
A. Mair
I. Majer
M. J. Makela
P. Manning
S. Mara
G. D. Marshall
M. R. Masjedi
P. Matignon
M. Maurer
S. Mavale-Manuel
E. Melén
E. Melo-Gomes
E. O. Meltzer
A. Menzies-Gow
H. Merk
J. P. Michel
N. Miculinic
F. Mihaltan
B. Milenkovic
G. M. Y. Mohammad
M. Molimard
I. Momas
A. Montilla-Santana
M. Morais-Almeida
M. Morgan
R. Mösges
J. Mullol
S. Nafti
L. Namazova-Baranova
R. Naclerio
A. Neou
H. Neffen
K. Nekam
B. Niggemann
G. Ninot
T. D. Nyembue
R. E. O’Hehir
K. Ohta
Y. Okamoto
K. Okubo
S. Ouedraogo
P. Paggiaro
I. Pali-Schöll
P. Panzner
N. Papadopoulos
A. Papi
H. S. Park
G. Passalacqua
I. Pavord
R. Pawankar
R. Pengelly
O. Pfaar
R. Picard
B. Pigearias
I. Pin
D. Plavec
D. Poethig
W. Pohl
T. A. Popov
F. Portejoie
P. Potter
D. Postma
D. Price
K. F. Rabe
F. Raciborski
F. Radier Pontal
S. Repka-Ramirez
S. Reitamo
S. Rennard
F. Rodenas
J. Roberts
J. Roca
L. Rodriguez Mañas
C. Rolland
M. Roman Rodriguez
A. Romano
J. Rosado-Pinto
N. Rosario
L. Rosenwasser
M. Rottem
D. Ryan
M. Sanchez-Borges
G. K. Scadding
H. J. Schunemann
E. Serrano
P. Schmid-Grendelmeier
H. Schulz
A. Sheikh
M. Shields
N. Siafakas
Y. Sibille
T. Similowski
F. E. R. Simons
J. C. Sisul
I. Skrindo
H. A. Smit
D. Solé
T. Sooronbaev
O. Spranger
R. Stelmach
P. J. Sterk
J. Sunyer
C. Thijs
T. To
A. Todo-Bom
M. Triggiani
R. Valenta
A. L. Valero
E. Valia
E. Valovirta
E. Van Ganse
M. van Hage
O. Vandenplas
T. Vasankari
B. Vellas
J. Vestbo
G. Vezzani
P. Vichyanond
G. Viegi
C. Vogelmeier
T. Vontetsianos
M. Wagenmann
B. Wallaert
S. Walker
D. Y. Wang
U. Wahn
M. Wickman
D. M. Williams
S. Williams
J. Wright
B. P. Yawn
P. K. Yiallouros
O. M. Yusuf
A. Zaidi
H. J. Zar
M. E. Zernotti
L. Zhang
N. Zhong
M. Zidarn
J. Mercier
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Clinical and Translational Allergy / Issue 1/2016
Electronic ISSN: 2045-7022
DOI
https://doi.org/10.1186/s13601-016-0116-9

Other articles of this Issue 1/2016

Clinical and Translational Allergy 1/2016 Go to the issue

Review

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies

Brief communication

Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot study

Research

Standardization of double blind placebo controlled food challenge with soy within a multicentre trial

Study protocol

Dietary intake and risk of asthma in children and adults: protocol for a systematic review and meta-analysis

Research

Exploratory analysis of CD63 and CD203c expression in basophils from hazelnut sensitized and allergic individuals

Brief communication

Very low prevalence of IgE mediated wheat allergy and high levels of cross-sensitisation between grass and wheat in a UK birth cohort